299 related articles for article (PubMed ID: 10791773)
21. Insulin-like growth factor binding proteins (IGFBPs) in breast cancer.
Perks CM; Holly JM
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):75-84. PubMed ID: 10791770
[TBL] [Abstract][Full Text] [Related]
22. Regulation of insulin-like growth factors by antiestrogen.
Winston R; Kao PC; Kiang DT
Breast Cancer Res Treat; 1994; 31(1):107-15. PubMed ID: 7526905
[TBL] [Abstract][Full Text] [Related]
23. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factors and breast cancer.
Lee AV; Yee D
Biomed Pharmacother; 1995; 49(9):415-21. PubMed ID: 8746077
[TBL] [Abstract][Full Text] [Related]
25. IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.
Brünner N; Moser C; Clarke R; Cullen K
Breast Cancer Res Treat; 1992; 22(1):39-45. PubMed ID: 1421423
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
27. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
28. [Insulin-like growth factors (IGF) and their binding proteins (IGFBP). Physiological and pathological regulation].
Le Bouc Y
Journ Annu Diabetol Hotel Dieu; 1995; ():29-38. PubMed ID: 7541484
[No Abstract] [Full Text] [Related]
29. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3.
Ma ZQ; Santagati S; Patrone C; Pollio G; Vegeto E; Maggi A
Mol Endocrinol; 1994 Jul; 8(7):910-8. PubMed ID: 7984152
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factors: polypeptides with diverse physiological roles.
Rechler MM
Mead Johnson Symp Perinat Dev Med; 1988; (32):12-20. PubMed ID: 2485435
[No Abstract] [Full Text] [Related]
31. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
Karl M; Potier M; Schulman IH; Rivera A; Werner H; Fornoni A; Elliot SJ
Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
33. Neurodevelopmental effects of insulin-like growth factor signaling.
O'Kusky J; Ye P
Front Neuroendocrinol; 2012 Aug; 33(3):230-51. PubMed ID: 22710100
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions.
Van Wyk JJ; Smith EP
J Clin Endocrinol Metab; 1999 Dec; 84(12):4349-54. PubMed ID: 10599687
[No Abstract] [Full Text] [Related]
35. Genetics, chemistry, and function of the IGF/IGFBP system.
Collett-Solberg PF; Cohen P
Endocrine; 2000 Apr; 12(2):121-36. PubMed ID: 10905372
[No Abstract] [Full Text] [Related]
36. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
37. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.
Martin MB; Franke TF; Stoica GE; Chambon P; Katzenellenbogen BS; Stoica BA; McLemore MS; Olivo SE; Stoica A
Endocrinology; 2000 Dec; 141(12):4503-11. PubMed ID: 11108261
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.
Dhar K; Banerjee S; Dhar G; Sengupta K; Banerjee SK
Cancer Res; 2007 Feb; 67(4):1520-6. PubMed ID: 17308090
[TBL] [Abstract][Full Text] [Related]
39. The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer.
Yee D; Rosen N; Favoni RE; Cullen KJ
Cancer Treat Res; 1991; 53():93-106. PubMed ID: 1672092
[TBL] [Abstract][Full Text] [Related]
40. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
